WELPANTO-LS contains Pantoprazole Sodium 40 mg (EC) + Levosulpiride 75 mg (SR), providing complementary acid-suppressive and gastroprokinetic action. A differentiated PCD Pharma Gastro offering.
GERD, dyspepsia and motility-related digestive symptoms.
To address acid secretion and impaired motility.
Take as prescribed, usually before meals. Inform the physician about neurological, hormonal or cardiac conditions and other medicines.
Headache, nausea, diarrhea, abdominal discomfort, dizziness and fatigue may occur.
WELPANTO-LS: Pantoprazole reduces gastric acid production, while Levosulpiride enhances gastrointestinal motility and supports gastric emptying.
